<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9226846</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">35543304</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9226846</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1002/brb3.2553</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">BRB32553</article-id></all-ids><extracted-table><table-id>brb32553-tbl-0001</table-id><table-label>TABLE 1</table-label><table-caption>Demographic, clinical, and neuropsychological test data of patients with type 2 diabetes mellitus and healthy controls</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="brb32553-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Demographic, clinical, and neuropsychological test data of patients with type 2 diabetes mellitus and healthy controls</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">T2DM (<italic toggle="yes">n </italic>= 44) (mean ± SD)</th><th align="left" rowspan="1" colspan="1">HCs (<italic toggle="yes">n </italic>= 41) (mean ± SD)</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">55.18 ± 6.25</td><td align="left" rowspan="1" colspan="1">54.41 ± 4.96</td><td align="left" rowspan="1" colspan="1">0.534</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (M/F)</td><td align="left" rowspan="1" colspan="1">31/13</td><td align="left" rowspan="1" colspan="1">27/14</td><td align="left" rowspan="1" colspan="1">0.649<xref rid="brb32553-tbl1-note-0003" ref-type="table-fn"><sup>#</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Education (years)</td><td align="left" rowspan="1" colspan="1">13.95 ± 2.57</td><td align="left" rowspan="1" colspan="1">14.85 ± 2.40</td><td align="left" rowspan="1" colspan="1">0.100</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">24.47 ± 2.92</td><td align="left" rowspan="1" colspan="1">24.19 ± 2.96</td><td align="left" rowspan="1" colspan="1">0.659</td></tr><tr><td align="left" rowspan="1" colspan="1">T2DM duration (years)</td><td align="left" rowspan="1" colspan="1">9.41 ± 5.28</td><td align="left" rowspan="1" colspan="1">–</td><td align="left" rowspan="1" colspan="1">–</td></tr><tr><td align="left" rowspan="1" colspan="1">FBG (mmol/L)</td><td align="left" rowspan="1" colspan="1">8.67 ± 2.72</td><td align="left" rowspan="1" colspan="1">5.25 ± 0.78</td><td align="left" rowspan="1" colspan="1">&lt;0.000<xref rid="brb32553-tbl1-note-0004" ref-type="table-fn">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1c (%)</td><td align="left" rowspan="1" colspan="1">8.09 ± 1.80</td><td align="left" rowspan="1" colspan="1">5.58 ± 0.54</td><td align="left" rowspan="1" colspan="1">&lt;0.000<xref rid="brb32553-tbl1-note-0004" ref-type="table-fn">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic BP (mmHg)</td><td align="left" rowspan="1" colspan="1">129.34 ± 21.16</td><td align="left" rowspan="1" colspan="1">122.43 ± 7.99</td><td align="left" rowspan="1" colspan="1">0.053</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic BP (mmHg)</td><td align="left" rowspan="1" colspan="1">81.70 ± 14.00</td><td align="left" rowspan="1" colspan="1">81.71 ± 5.55</td><td align="left" rowspan="1" colspan="1">0.999</td></tr><tr><td align="left" rowspan="1" colspan="1">TG (mmol/L)</td><td align="left" rowspan="1" colspan="1">1.88 ± 1.25</td><td align="left" rowspan="1" colspan="1">1.81 ± 1.23</td><td align="left" rowspan="1" colspan="1">0.803</td></tr><tr><td align="left" rowspan="1" colspan="1">TC (mmol/L)</td><td align="left" rowspan="1" colspan="1">4.41 ± 1.15</td><td align="left" rowspan="1" colspan="1">4.84 ± 0.83</td><td align="left" rowspan="1" colspan="1">0.061</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL‐C(mmol/L)</td><td align="left" rowspan="1" colspan="1">1.10 ± 0.20</td><td align="left" rowspan="1" colspan="1">1.23 ± 0.38</td><td align="left" rowspan="1" colspan="1">0.054</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL‐C (mmol/L)</td><td align="left" rowspan="1" colspan="1">2.52 ± 0.71</td><td align="left" rowspan="1" colspan="1">2.81 ± 0.88</td><td align="left" rowspan="1" colspan="1">0.094</td></tr><tr><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">28.57 ± 1.35</td><td align="left" rowspan="1" colspan="1">28.46 ± 1.55</td><td align="left" rowspan="1" colspan="1">0.713</td></tr><tr><td align="left" rowspan="1" colspan="1">MoCA</td><td align="left" rowspan="1" colspan="1">25.47 ± 2.79</td><td align="left" rowspan="1" colspan="1">26.82 ± 1.64</td><td align="left" rowspan="1" colspan="1">0.009<xref rid="brb32553-tbl1-note-0004" ref-type="table-fn">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">TMT‐A (seconds)</td><td align="left" rowspan="1" colspan="1">77.47 ± 32.72</td><td align="left" rowspan="1" colspan="1">70.38 ± 29.23</td><td align="left" rowspan="1" colspan="1">0.039<xref rid="brb32553-tbl1-note-0004" ref-type="table-fn">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">CDT</td><td align="left" rowspan="1" colspan="1">19.05 ± 8.49</td><td align="left" rowspan="1" colspan="1">20.97 ± 6.46</td><td align="left" rowspan="1" colspan="1">0.269</td></tr></tbody></table><table-wrap-foot><fn id="brb32553-tbl1-note-0001"><p><italic toggle="yes">Note</italic>: Values distributed normally or nonnormally are presented as mean ± SD or median (minimum, maximum).</p></fn><fn id="brb32553-tbl1-note-0002"><p>Abbreviations: BMI, body mass index; BP, blood pressure; CDT, Clock‐Drawing Test; F, female; FBG, fasting blood glucose; HbA1c, glycated hemoglobin; HC, healthy control; LDL‐C, low‐density lipoprotein cholesterol; M, male; MMSE, Mini‐Mental State Examination; MoCA, Montreal Cognitive Assessment; TC, total cholesterol; TG, triglyceride; TMT‐A, Trail Making Test‐A; T2DM, type 2 diabetes mellitus.</p></fn><fn id="brb32553-tbl1-note-0003"><label><sup>#</sup></label><p>Pearson's <italic toggle="yes">χ</italic><sup>2</sup> test.</p></fn><fn id="brb32553-tbl1-note-0004"><label>*</label><p><italic toggle="yes">p</italic> &lt; .05.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic, clinical, and neuropsychological test data of patients with type 2 diabetes mellitus and healthy controls</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="left"/><col align="left"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left"/><th align="left">T2DM (n = 44) (mean ± SD)</th><th align="left">HCs (n = 41) (mean ± SD)</th><th align="left">p value</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="left">55.18 ± 6.25</td><td align="left">54.41 ± 4.96</td><td align="left">0.534</td></tr><tr><td align="left">Sex (M/F)</td><td align="left">31/13</td><td align="left">27/14</td><td align="left">0.649???</td></tr><tr><td align="left">Education (years)</td><td align="left">13.95 ± 2.57</td><td align="left">14.85 ± 2.40</td><td align="left">0.100</td></tr><tr><td align="left">BMI (kg/m2)</td><td align="left">24.47 ± 2.92</td><td align="left">24.19 ± 2.96</td><td align="left">0.659</td></tr><tr><td align="left">T2DM duration (years)</td><td align="left">9.41 ± 5.28</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">FBG (mmol/L)</td><td align="left">8.67 ± 2.72</td><td align="left">5.25 ± 0.78</td><td align="left">&lt;0.000???</td></tr><tr><td align="left">HbA1c (%)</td><td align="left">8.09 ± 1.80</td><td align="left">5.58 ± 0.54</td><td align="left">&lt;0.000???</td></tr><tr><td align="left">Systolic BP (mmHg)</td><td align="left">129.34 ± 21.16</td><td align="left">122.43 ± 7.99</td><td align="left">0.053</td></tr><tr><td align="left">Diastolic BP (mmHg)</td><td align="left">81.70 ± 14.00</td><td align="left">81.71 ± 5.55</td><td align="left">0.999</td></tr><tr><td align="left">TG (mmol/L)</td><td align="left">1.88 ± 1.25</td><td align="left">1.81 ± 1.23</td><td align="left">0.803</td></tr><tr><td align="left">TC (mmol/L)</td><td align="left">4.41 ± 1.15</td><td align="left">4.84 ± 0.83</td><td align="left">0.061</td></tr><tr><td align="left">HDL‐C(mmol/L)</td><td align="left">1.10 ± 0.20</td><td align="left">1.23 ± 0.38</td><td align="left">0.054</td></tr><tr><td align="left">LDL‐C (mmol/L)</td><td align="left">2.52 ± 0.71</td><td align="left">2.81 ± 0.88</td><td align="left">0.094</td></tr><tr><td align="left">MMSE</td><td align="left">28.57 ± 1.35</td><td align="left">28.46 ± 1.55</td><td align="left">0.713</td></tr><tr><td align="left">MoCA</td><td align="left">25.47 ± 2.79</td><td align="left">26.82 ± 1.64</td><td align="left">0.009???</td></tr><tr><td align="left">TMT‐A (seconds)</td><td align="left">77.47 ± 32.72</td><td align="left">70.38 ± 29.23</td><td align="left">0.039???</td></tr><tr><td align="left">CDT</td><td align="left">19.05 ± 8.49</td><td align="left">20.97 ± 6.46</td><td align="left">0.269</td></tr></tbody></table></div>Note: Values distributed normally or nonnormally are presented as mean ± SD or median (minimum, maximum).Abbreviations: BMI, body mass index; BP, blood pressure; CDT, Clock‐Drawing Test; F, female; FBG, fasting blood glucose; HbA1c, glycated hemoglobin; HC, healthy control; LDL‐C, low‐density lipoprotein cholesterol; M, male; MMSE, Mini‐Mental State Examination; MoCA, Montreal Cognitive Assessment; TC, total cholesterol; TG, triglyceride; TMT‐A, Trail Making Test‐A; T2DM, type 2 diabetes mellitus.#Pearson's χ2 test.*p &lt; .05.John Wiley &amp; Sons, Ltd.</transformed-table></extracted-table><extracted-table><table-id>brb32553-tbl-0002</table-id><table-label>TABLE 2</table-label><table-caption>Aberrant functional connectivity in patients with type 2 diabetes compared with healthy controls</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="brb32553-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Aberrant functional connectivity in patients with type 2 diabetes compared with healthy controls</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th style="border-bottom:solid 1px #000000" colspan="3" align="left" rowspan="1">MNI coordinates</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Brain region</th><th align="left" rowspan="1" colspan="1">BA</th><th align="left" rowspan="1" colspan="1">X</th><th align="left" rowspan="1" colspan="1">Y</th><th align="left" rowspan="1" colspan="1">Z</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">T</italic> value</th><th align="left" rowspan="1" colspan="1">Cluster size</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">R inferior frontal gyrus</td><td align="char" rowspan="1" colspan="1">46</td><td align="char" rowspan="1" colspan="1">54</td><td align="char" rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">−4.409</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">&lt;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">R middle frontal gyrus</td><td align="char" rowspan="1" colspan="1">9</td><td align="char" rowspan="1" colspan="1">39</td><td align="char" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">−5.122</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">&lt;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">R precuneus/posterior cingulate cortex</td><td align="char" rowspan="1" colspan="1">31</td><td align="char" rowspan="1" colspan="1">3</td><td align="char" rowspan="1" colspan="1">−51</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">−4.325</td><td align="left" rowspan="1" colspan="1">57</td><td align="left" rowspan="1" colspan="1">&lt;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">B medial prefrontal cortex</td><td align="char" rowspan="1" colspan="1">8</td><td align="char" rowspan="1" colspan="1">−3</td><td align="char" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">−4.443</td><td align="left" rowspan="1" colspan="1">82</td><td align="left" rowspan="1" colspan="1">&lt;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">L angular gyrus</td><td align="char" rowspan="1" colspan="1">39</td><td align="char" rowspan="1" colspan="1">−42</td><td align="char" rowspan="1" colspan="1">−63</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">−4.453</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">&lt;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">R angular gyrus</td><td align="char" rowspan="1" colspan="1">40</td><td align="char" rowspan="1" colspan="1">48</td><td align="char" rowspan="1" colspan="1">−60</td><td align="left" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">−4.372</td><td align="left" rowspan="1" colspan="1">82</td><td align="left" rowspan="1" colspan="1">&lt;0.05</td></tr></tbody></table><table-wrap-foot><fn id="brb32553-tbl2-note-0001"><p>Abbreviations: B, bilateral; BA, Brodmann's area; L, left; MNI, Montreal Neurological Institute; R, right.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Aberrant functional connectivity in patients with type 2 diabetes compared with healthy controls</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><thead><tr><th align="left"/><th align="left"/><th style="border-bottom:solid 1px #000000" colspan="3" align="left">MNI coordinates</th><th align="left"/><th align="left"/><th align="left"/></tr><tr style="border-bottom:solid 1px #000000"><th align="left">Brain region</th><th align="left">BA</th><th align="left">X</th><th align="left">Y</th><th align="left">Z</th><th align="left">T value</th><th align="left">Cluster size</th><th align="left">p</th></tr></thead><tbody><tr><td align="left">R inferior frontal gyrus</td><td align="char">46</td><td align="char">54</td><td align="char">33</td><td align="left">15</td><td align="left">−4.409</td><td align="left">34</td><td align="left">&lt;0.05</td></tr><tr><td align="left">R middle frontal gyrus</td><td align="char">9</td><td align="char">39</td><td align="char">24</td><td align="left">39</td><td align="left">−5.122</td><td align="left">55</td><td align="left">&lt;0.05</td></tr><tr><td align="left">R precuneus/posterior cingulate cortex</td><td align="char">31</td><td align="char">3</td><td align="char">−51</td><td align="left">27</td><td align="left">−4.325</td><td align="left">57</td><td align="left">&lt;0.05</td></tr><tr><td align="left">B medial prefrontal cortex</td><td align="char">8</td><td align="char">−3</td><td align="char">36</td><td align="left">48</td><td align="left">−4.443</td><td align="left">82</td><td align="left">&lt;0.05</td></tr><tr><td align="left">L angular gyrus</td><td align="char">39</td><td align="char">−42</td><td align="char">−63</td><td align="left">36</td><td align="left">−4.453</td><td align="left">45</td><td align="left">&lt;0.05</td></tr><tr><td align="left">R angular gyrus</td><td align="char">40</td><td align="char">48</td><td align="char">−60</td><td align="left">42</td><td align="left">−4.372</td><td align="left">82</td><td align="left">&lt;0.05</td></tr></tbody></table></div>Abbreviations: B, bilateral; BA, Brodmann's area; L, left; MNI, Montreal Neurological Institute; R, right.John Wiley &amp; Sons, Ltd.</transformed-table></extracted-table></extracted-tables-set>